RobertRReversMD

PubMed

• 50 citations
  In vivo deactivation of proinsulin action on glucose disposal and hepatic glucose production in normal man.
  Harry Glauber, Robert R. Revers, Robert R. Henry, L Schmeiser, Penny Wallace, Orville G. Kolterman, Robert M. Cohen, Arthur H. Rubenstein, John A Galloway, Bruce H. Fr...> ;Diabetes. 1986 Mar 1
• 38 citations
  Modulation of insulin secretion by insulin and glucose in type II diabetes mellitus.
  W. Timothy Garvey, Robert R. Revers, Orville G. Kolterman, Arthur H. Rubenstein, Jerrold M. Olefsky> ;The Journal of Clinical Endocrinology and Metabolism. 1985 Mar 1
• 65 citations
  The Metabolic Clearance of Insulin and the Feedback Inhibition of Insulin Secretion Are Altered with Aging
  R I Fink, Robert R. Revers, Orville G. Kolterman, Jerrold M. Olefsky> ;Diabetes. 1985 Mar 1
• 15 citations
  Insulin resistance in non-insulin dependent (type II) and insulin dependent (type I) diabetes mellitus.
  Jerrold M. Olefsky, Robert R. Revers, Mel Prince, Robert R. Henry, W T Garvey, John A. Scarlett, Orville G. Kolterman> ;Advances in Experimental Medicine and Biology. 1985 Jan 1
• 38 citations
  A radioimmunoassay for circulating human proinsulin.
  Robert M. Cohen, Tomio Nakabayashi, Petra M. Blix, Paul A. Rue, Steven E. Shoelson, Mary A Root, Bruce Hill Frank, Robert R. Revers, Arthur H. Rubenstein> ;Diabetes. 1985 Jan 1
• The effects of biosynthetic human proinsulin on carbohydrate metabolism.
  Revers, R. R., Henry, R., Schmeiser, L., Kolterman, O., Cohen, R., Bergenstal, R., Polonsky, K., Jaspan, J., Rubenstein, A., Frank, B.> ;Diabetes. 1984 Aug
• 44 citations
  The metabolic effects of biosynthetic human proinsulin in individuals with type I diabetes.
  R. M. Bergenstal, Robert M. Cohen, E. Lever, Kenneth S. Polonsky, J. Jaspan, P. M. Blix, Robert R. Revers, Jerrold M. Olefsky, Orville G. Kolterman, K. Steiner, Alan D...> ;The Journal of Clinical Endocrinology and Metabolism. 1984 Jun 1
• 21 citations
  Biosynthetic human insulin and proinsulin have additive but not synergistic effects on total body glucose disposal.
  Robert R. Revers, Robert R. Henry, L Schmeiser, Orville G. Kolterman, Robert M. Cohen, Arthur H. Rubenstein, Bruce H. Frank, John A Galloway, Jerrold M. Olefsky> ;The Journal of Clinical Endocrinology and Metabolism. 1984 Jun 1
• 124 citations
  Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
  Robert R. Revers, R I Fink, J Griffin, Jerrold M. Olefsky, Orville G. Kolterman> ;The Journal of Clinical Investigation. 1984 Mar 1
• 65 citations
  Lack of in Vivo Insulin Resistance in Controlled Insulin-Dependent, Type I, Diabetic Patients*
  Robert R. Revers, Orville G. Kolterman, John A. Scarlett, R.Stuart Gray, Jerrold M. Olefsky> ;The Journal of Clinical Endocrinology and Metabolism. 1984 Feb 1
• 29 citations
  Relationship Between Serum Glucose Level and the Metabolic Clearance Rate of Glucose in Non-insulin-dependent Diabetes Mellitus
  Robert R. Revers, Orville G. Kolterman, Jerrold M. Olefsky> ;Diabetes. 1983 Jul 1
• 43 citations
  Rheumatic syndromes in endocrine disease
  John H.L. Bland, John W. Frymoyer, Arthur H. Newberg, Robert Revers, Richard J. Norman> ;Seminars in Arthritis and Rheumatism. 1979 Aug 1
• Join now to see all